Eric J Ende insider trades
Open-market stock purchases and sales by Eric J Ende, Director at Avadel Pharmaceuticals plc, from SEC Form 4 filings since Jun 16, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $4.6M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $12K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $122K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $201K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $465K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $119K |
Companies traded
- AVDL Avadel Pharmaceuticals plc: 12 buys, last Feb 12, 2026
- MTNB Matinas BioPharma Holdings, Inc: 3 buys, last Nov 1, 2023
- NBSE NeuBase Therapeutics, Inc: other filings, last Sep 9, 2022
- PGNX Progenics Pharmaceuticals Inc: other filings, last Jun 19, 2020
- GENZ Genzyme Corp: other filings, last Apr 4, 2011